View Agent
| Agent Info | |
| Agent: | icotinib |
| Synonyms: | Conmana;Conmanna;Icotinib;BPI-2009-H |
| Drug Status For Certain Diseases: | Non-small-cell lung cancer(phase II) |
| Classification: | a new first-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors |
| Target: | Epidermal growth factor receptor |
| KEGG Pathway: | NA |
| Wiki Pathway: | Arylhydrocarbon receptor (AhR) signaling pathway TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer Signaling by ERBB4 EGF/EGFR Signaling Pathway Aryl Hydrocarbon Receptor Pathway Hair Follicle Development Gastric cancer network 2 miR-targeted genes in lymphocytes - TarBase miR-targeted genes in epithelium - TarBase miR-targeted genes in muscle cell - TarBase Spinal Cord Injury ErbB Signaling Pathway MAPK Signaling Pathway Focal Adhesion Hair Follicle Development Signaling by EGFR Bladder Cancer Signaling Pathways in Glioblastoma AGE/RAGE pathway Extracellular vesicle-mediated signaling in recipient cells Integrated Pancreatic Cancer Pathway PIP3 activates AKT signaling Signaling by ERBB2 Integrated Breast Cancer Pathway Regulation of Actin Cytoskeleton Nanoparticle-mediated activation of receptor signaling L1CAM interactions Aryl Hydrocarbon Receptor Gastrin-CREB signalling pathway via PKC and MAPK |